Fusix Biotech, Dymium and Opsyon Therapeutics were persuasive in this year's business plan phase of the Science4Life Venture Cup. The Munich-based start-up Fusix Biotech took third place and aims to offer patients with difficult-to-treat cancers safe and effective immunotherapeutic approaches with the help of its platform technology.
In the Science4Life Venture Cup, Fusix Biotech from Munich convinced the jury. The start-up took third place with its idea of offering patients with difficult-to-treat cancers safe and effective immunotherapeutic therapy approaches with the help of a platform technology.
The winners from Munich also included Dymium and Opsyon:
Dymium from Garching offers the world's first method for residue-free kidney stone removal using a magnetic separation technology. The interdisciplinary group works at the Bioseparation Engineering Group of the Technical University of Munich and at the Klinikum rechts der Isar.
Opsyon Therapeutics is a spin-off project of Ludwig-Maximilians Universität München and develops novel immunotherapies by combining immune checkpoint inhibition with antibody-based tumor targeting in one drug. The technology is expected to provide cancer patients with an effective therapy with reduced systemic side effects and the possibility of long-term survival and improved quality of life. Opsyon is focused on the aggressive hematological disease acute myeloid leukemia (AML) as well as pancreatic and ovarian cancer.
For the first time since 2019, the final awards ceremony of the Science4Life Venture Cup and Science4Life Energy Cup of the independent start-up initiative Science4Life e.V. was once again able to take place on a grand scale in Frankfurt.
The top placements of the Science4Life Venture Cup
First place in the Science4Life Venture Cup, and with it 25,000 euros in prize money, went to CatSper. The team from Münster is developing a new laboratory test that can make the male fertility disorder "cat sper dysfunction" medically visible for the first time and thus provide diagnostic indications for early detection. Second place goes to DNTOX from Düsseldorf: The team offers a currently unique, animal-free analysis of chemicals - a more cost-effective alternative to resource-intensive and ethically controversial animal testing.
Every year, the independent start-up initiative Science4Life e.V. invites idea creators from all over Germany to turn innovative business ideas from the fields of life sciences, chemistry and energy into corporate successes.
The next and now 25th round of the Science4Life competition will start this year on September 1, 2022 with the idea phase.